|
RNF103 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.369900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.116800E-01 |
| Normal-vs-Stage2 |
2.242200E-01 |
| Normal-vs-Stage3 |
9.420300E-03 |
| Normal-vs-Stage4 |
1.566300E-04 |
| Stage1-vs-Stage2 |
4.594200E-01 |
| Stage1-vs-Stage3 |
2.030200E-02 |
| Stage1-vs-Stage4 |
4.381300E-04 |
| Stage2-vs-Stage3 |
4.891600E-01 |
| Stage2-vs-Stage4 |
1.275370E-01 |
| Stage3-vs-Stage4 |
2.154000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.004300E-02 |
| Normal-vs-AfricanAmerican |
2.184400E-01 |
| Normal-vs-Asian |
7.101400E-01 |
| Caucasian-vs-AfricanAmerican |
6.507200E-01 |
| Caucasian-vs-Asian |
6.946400E-01 |
| AfricanAmerican-vs-Asian |
8.132800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.180000E-03 |
| Normal-vs-Female |
9.873200E-01 |
| Male-vs-Female |
3.54610000000699E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.621800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.039700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.290200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.297400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.295400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.752800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.050800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.957400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.443000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.903400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.473200E-01 |
| Normal-vs-Grade 2 |
9.967400E-01 |
| Normal-vs-Grade 3 |
5.976900E-04 |
| Normal-vs-Grade 4 |
4.23849999997561E-06 |
| Grade 1-vs-Grade 2 |
3.673800E-01 |
| Grade 1-vs-Grade 3 |
4.358500E-03 |
| Grade 1-vs-Grade 4 |
1.640050E-04 |
| Grade 2-vs-Grade 3 |
2.4607999999926E-05 |
| Grade 2-vs-Grade 4 |
2.38259999951751E-07 |
| Grade 3-vs-Grade 4 |
8.936100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.086200E-01 |
| Normal-vs-ccB subtype |
5.399200E-04 |
| ccA subtype-vs-ccB subtype |
1.52339999948126E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.118500E-02 |
| Normal-vs-N1 |
7.503000E-03 |
| N0-vs-N1 |
1.793380E-01 |
|
|
